» Articles » PMID: 15334056

Transformation Suppressor Protein Pdcd4 Interferes with JNK-mediated Phosphorylation of C-Jun and Recruitment of the Coactivator P300 by C-Jun

Overview
Journal Oncogene
Date 2004 Aug 31
PMID 15334056
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The transformation suppressor gene Pdcd4 (programmed cell death gene 4) inhibits the tumor-promoter mediated transformation of mouse keratinocytes and has recently been implicated as a potential tumor suppressor gene in the development of human lung cancer. Biochemical analysis has suggested that the Pdcd4 protein is involved in protein translation as well as in nuclear events. Recent work has shown that Pdcd4 suppresses the transactivation of AP-1 responsive promoters by c-Jun, suggesting that the transformation-suppressor activity of Pdcd4 might be due, at least in part, to the inhibition of c-Jun activity. Here, we have addressed how Pdcd4 inhibits c-Jun. We show that Pdcd4 interferes with the phosphorylation of c-Jun by Jun N-terminal kinase (JNK). The inhibition of c-Jun phosphorylation by Pdcd4 appears not to be due to a general suppression of JNK activity, our data rather suggest that Pdcd4 interacts with c-Jun and thereby blocks phosphorylation of c-Jun. In addition to affecting c-Jun phosphorylation, Pdcd4 blocks the recruitment of the coactivator p300 by c-Jun. Taken together, our results strongly suggest that Pdcd4 is directly involved in the regulation of c-Jun activity.

Citing Articles

The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance.

Wang Q, Yang H Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459035 PMC: 11510623. DOI: 10.3390/ph17101396.


Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus.

Araki Y, Mimura T Int J Mol Sci. 2024; 25(2).

PMID: 38256093 PMC: 10816225. DOI: 10.3390/ijms25021019.


Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases.

Zhai Y, Wang T, Fu Y, Yu T, Ding Y, Nie H Int J Mol Sci. 2023; 24(9).

PMID: 37175715 PMC: 10178416. DOI: 10.3390/ijms24098011.


Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression.

Yang W, George A, Wang C, Yang R, Duncan A, Patel D Curr Oncol. 2023; 30(2):1614-1625.

PMID: 36826085 PMC: 9955764. DOI: 10.3390/curroncol30020124.


Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications.

Mladenov M, Bogdanov J, Bogdanov B, Hadzi-Petrushev N, Kamkin A, Stojchevski R Mol Med. 2022; 28(1):129.

PMID: 36316651 PMC: 9620630. DOI: 10.1186/s10020-022-00559-5.